At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
03759 PHARMARON
Not Yet Opened 05-21 16:08:15
18.650
+0.370
+2.02%
High19.000
Low18.290
Vol4.86M
Open18.290
D1 Closing18.280
Amplitude3.88%
Mkt Cap34.13B
Tradable Cap6.58B
Total Shares1.83B
T/O91.02M
T/O Rate1.38%
Tradable Shares353.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Ariel Investments Boosts Stake in Pharmaron with 900,700 Share Purchase
Pharmaron Beijing Co Ltd is a China-based company mainly engaged in pharmaceutical research and development. The Company operates through five segments. The Laboratory Services segment includes laboratory chemistry and bioscience services, covering small molecule drugs, oligonucleotides, peptides, antibodies, antibody-drug conjugates, and cell and gene therapy products. The Chemical and Formulation Process Development and Manufacturing Services segment includes active pharmaceutical ingredient process development and manufacturing, as well as preformulation and formulation development. The Clinical Research Services segment includes international and domestic clinical research services. The Large Molecule and Cell and Gene Therapy Services segment includes large molecule drug discovery, development, and manufacturing services, as well as cell and gene therapy laboratory and gene therapy drug development and manufacturing services. The Company also operates through the others segment.